Happel David 4
4 · Sagimet Biosciences Inc. · Filed Nov 20, 2023
Insider Transaction Report
Form 4
Happel David
DirectorPresident & CEO
Transactions
- Purchase
Series A Common Stock
2023-11-16$2.35/sh+590$1,387→ 590 total
Footnotes (1)
- [F1]Reflects the weighted average price. The shares were purchased in multiple transactions at prices ranging from $2.31 per share to $2.40 per share. The Reporting Person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each price.